BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32197732)

  • 1. Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.
    Coon CD; Hanlon J; Abel JL; Lundy JJ; Carson RT; Reasner DS
    Value Health; 2020 Mar; 23(3):362-369. PubMed ID: 32197732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.
    McLeod L; Ervin C; Fehnel SE; Eremenco S; Carson RT; Hanlon J; Coons SJ;
    Value Health; 2024 May; 27(5):614-622. PubMed ID: 38311181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation.
    Williams VS; Nelson LM; Fehnel SE; MacDougall J; Carson RT; Tourkodimitris S; Kurtz C; Baird MJ; Johnston JM
    Aliment Pharmacol Ther; 2014 Aug; 40(3):298-308. PubMed ID: 24943204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
    Bouchoucha M; Devroede G; Mary F; Bon C; Bejou B; Benamouzig R
    Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?
    Tack J
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):21-6. PubMed ID: 23859757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.
    Spiegel B; Camilleri M; Bolus R; Andresen V; Chey WD; Fehnel S; Mangel A; Talley NJ; Whitehead WE
    Gastroenterology; 2009 Dec; 137(6):1944-53.e1-3. PubMed ID: 19706292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.
    Chen HD; Bair MJ; Chang WC; Hsu CS; Wong MW; Hung JS; Liu TT; Yi CH; Lei WY; Chen CL
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):75-80. PubMed ID: 30922615
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
    World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
    Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
    Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent structure of irritable bowel syndrome symptom severity.
    Jasper F; Egloff B; Roalfe A; Witthöft M
    World J Gastroenterol; 2015 Jan; 21(1):292-300. PubMed ID: 25574104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
    Pei LX; Geng H; Chen H; Wu XL; Chen L; Zhou JL; Ju L; Lu G; Xu WL; Qin S; Guo J; Yang EM; Sun JH
    Trials; 2018 Oct; 19(1):529. PubMed ID: 30285891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome.
    Jarrett ME; Han CJ; Cain KC; Burr RL; Shulman RJ; Barney PG; Naliboff BD; Zia J; Heitkemper MM
    Neurogastroenterol Motil; 2016 Jul; 28(7):1094-103. PubMed ID: 26993039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Chang L; Lacy BE; Moshiree B; Kassebaum A; Abel JL; Hanlon J; Bartolini W; Boinpally R; Bochenek W; Fox SM; Mallick M; Tripp K; Omniewski N; Shea E; Borgstein N
    Am J Gastroenterol; 2021 Sep; 116(9):1929-1937. PubMed ID: 34465695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
    Su AM; Shih W; Presson AP; Chang L
    Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
    Ljótsson B; Jones M; Talley NJ; Kjellström L; Agréus L; Andreasson A
    United European Gastroenterol J; 2020 Apr; 8(3):284-292. PubMed ID: 32213021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel Syndrome with Constipation.
    Brenner DM; Sharma A; Rao SSC; Laitman AP; Heimanson Z; Allen C; Sayuk GS
    Dig Dis Sci; 2024 May; 69(5):1731-1738. PubMed ID: 38594429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM; Tack J; Chey WD; Rao SS; Fortea J; Falques M; Diaz C; Shiff SJ; Currie MG; Johnston JM
    Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.